BerGenBio's IPO

BerGenBio raised a round of funding on April 06, 2017. Investors include Public.

BerGenBio is an oncology-based biopharmaceutical company focused on pursuing therapeutic treatments for cancer and supporting the screening and identification of a wide array of potential targets in c…

Articles about BerGenBio's IPO: